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APATZIDOU eT Al. implying that these cells may contribute to periodontal healing once the infection is controlled. 7 However, the role of SCs in gingival tissue homeostasis and/or pathologies remains unclear. Multipotent stromal SCs were isolated from human periodontal GT and these cells improved osseous repair in critical size defects in mice. 8 MSC-like populations have been found within inflamed gingival tissue to be functionally equivalent to those derived from healthy gingival tissue 9 while gingival-derived MSCs have been shown to exhibit immunemodulatory and anti-inflammatory activity. 10, 11 Taken all together, it is speculated that MSC populations within infected GT promotes healing while dampening inflammation. Human MSCs were isolated from palatal connective tissue and periodontal GT to evaluate comparatively their properties. 12 Despite differences in colony-forming unit fibroblasts, population-doubling times, migration potential and level of surface marker expression, MSCs from both sources were relatively uniform in their ultrastructure and successfully differentiated into osteogenic, adipogenic and chondrogenic lineages. 
| MATERIAL AND ME THODS

| Study cohort and clinical interventions
Fifteen systemically healthy non-smokers with chronic periodontitis who were scheduled to receive periodontal surgery were recruited at the Department of Preventive Dentistry, Periodontology and Implant Biology (PDP&IB), Aristotle University of Thessaloniki (AUTh), Greece. The study was approved by the School's Ethical
Committee (22/11-01-2016 ) and all participants provided informed consent.
Inclusion criteria consisted of periodontal pockets of probing pocket depth (PPD) and clinical attachment levels >5 mm with bleeding on probing (BOP) and radiographic evidence of advanced bone loss. Exclusion criteria were >65 years of age, history of systemic disease, compromised medical conditions requiring prophylactic antibiotic coverage, antibiotic therapy within the last 3 months, bisphosphonate medication, bone metabolic diseases or disorders that compromise wound healing, use of anti-inflammatory drugs, radiation or immunosuppressive therapy, narrow zone/absence of attached gingiva, pregnancy/lactation, smoking and previous periodontal surgery.
Patients were screened for eligibility by a single calibrated examiner (DAA), who also performed the clinical (PPD, clinical attachment level, BOP, plaque index) and radiographic assessment.
Eligible subjects underwent cause-related periodontal treatment, which comprised strict plaque control measures (reiterated over the study period) and full-mouth hand/power-driven instrumentation under local anesthesia. At 6 months, the subjects were scheduled to undergo periodontal surgery. 13 Before anesthesia, gingival crevicular fluid and subgingival plaque samples were collected from a diseased and a clinically healthy (PPD ≤3 mm, absence of BOP, no radiographic evidence of bone loss) site in each individual. The designated sites were gently air dried and isolated from saliva by placing cotton rolls and using a saliva ejector. Supragingival plaque was carefully removed and gingival crevicular fluid samples were obtained by using paper strips (Periopaper, OraFlow Inc., Smithtown, NY, USA). The strips were placed in the periodontal pocket/sulcus until mild resistance was felt and were left in situ for 30 seconds, taking care to avoid mechanical trauma. Subsequently, subgingival plaque was collected by inserting 2 sterile paper points (ROEKO ISO-40; Coltène-Whaledent GmbH, Co. KG, Langenau, Germany)
in each site for 30 seconds. They were then stored in Eppendorf tubes (Eppendorf, Hamburg, Germany) at −80°C until further processed. GT was surgically harvested from the denoted sites that were non-adjacent and preferably in the same quadrant. An internal bevel combined with an intrasulcular incision demarcated a collar of soft tissues and following flap elevation, GT was sharply excised from the apical part of the pocket; 50% of the tissue was used for cytokine analysis and the remaining 50% for isolation/expansion of MSCs. A thin zone of the soft tissues lining the designated healthy sulcus was also harvested and was processed in a similar manner to the GT biopsy.
| Mesenchymal stem cell culture and characterization
The GT biopsy designated for MSC culture (GT-MSCs) and the analogous disease-free specimen of gingival connective tissue (G-MSCs) were enzymatically digested as described previously, 14 
| Gene expression in tissue
The section of the biopsy sample was placed into RNA-later (Sigma- 
| Cytokine levels in gingival crevicular fluid
Enzyme-linked immunosorbent assay and specific kits for IL-1β, IL-6, IL-10, TNF-α, IL-17A, IL-17E (Pepro Tech, London UK) and TGF-β (Mabtech AB, Stockholm Sweden) were used for cytokine measurements in gingival crevicular fluid. Minimum detection limits were IL-1β, IL-6, IL-10, TNF-α and IL-17A, all 1.9 pg/mL; IL-17E and TGF-β, both 3.9 pg/mL.
| Quantities of subgingival plaque microorganisms
The Epicentre Masterpure Gram-positive DNA isolation kit (Cambio, Cambridge, UK) was used to prepare genomic DNA from the plaque samples and from known quantities of laboratory strains of the target microorganisms. The amount and purity of DNA was checked spectroscopically. Real-time PCR analysis was used to determine copy numbers of Porphyromonas gingivalis, 16 Aggregatibacter actinomycetemcomitans, Fusobacterium nucleatum, Tannerella forsythia, 17 Treponema denticola 18 and Streptococcus mitis 19 in subgingival plaque. Known numbers of the target microbes were used to create standard curves from which copy numbers of unknown samples were determined.
| Statistical analyses
Statistical power calculation was based on the assumptions that the data were dependent and either normally distributed or log-normally distrib- Otherwise, the paired data sets (GT and disease-free tissues) were analyzed using spss version 21 (IBM Corp., Armonk, NY, USA and GraphPad Prism V5, La Jolla, CA, USA). Correlation between the biochemical and microbial parameters were evaluated with the Kendal Tau test.
Biological specimens and clinical data were coded, so that the laboratory analysis was blind to the clinical details.
| RE SULTS
| Clinical data
All periodontal defects (n = 15) were located in posterior segments.
Demographic details of the participants and clinical data are shown in Table 1 . GT-MSCs and G-MSCs (all P > .5; Figure 2 ).
| Mesenchymal stem cell cultures
| Cytokine and bacterial profiles
The expression of several proinflammatory cytokines was significantly higher in GT compared with the disease-free biopsy tissue (IL-1β: P = .007; TNF-α: P = .0001; IL-6: P = .011; IL-17A: P = .0001; Figure 3A ,B,C,E, respectively). Despite the observation that median levels were higher for IL-10, IL-17E or TGF-β mRNAs inside GT, this failed to reach statistical significance (all P > .1; Figure 3D ,F,H). There was a significantly higher ratio of IL-17A/IL-17E mRNA in the GT compared with the disease-free tissue specimens (P = .001; Figure 3G ). The amounts of TNF-α were significantly higher in gingival crevicular fluid sampled from the GT-associated site than the disease-free site (P < .039; Figure 4B ). Amounts of IL-17E were significantly lower in the gingival crevicular fluid samples from the diseased sites, in parallel with a significantly higher IL-17A/IL-17E ratio (P < .0054, P = .008, respectively; Figure 4F ,G). In contrast, there was no significant difference in the amounts of the other cytokines measured in the gingival crevicular fluid of diseased sites vs disease-free sites (P > .10; Figure 4A ,C,D,E,H).
The median copy numbers of P. gingivalis (P = .021), F. nucleatum (P = .003), T. denticola (P = .035) and T. forsythia (P = .0052) were significantly higher in the GT-associated plaque samples compared to the disease-free samples ( Figure 5A ,B,C,D, respectively). In contrast, the median copy numbers of A. actinomycetemcomitans and S. mitis tended to be lower in the GT samples but failed to reach statistical significance (both P > .1; Figure 5E ,F).
| Correlation analyses
Significant correlations were observed between cytokines in gingival crevicular fluid and the CD markers on MSCs isolated from GT (Table 2) F I G U R E 2 Summary data of flow cytometry, for stem cell markers expressed in GT (GT-MSC) and in G (G-MSC) specimens of 10 patients. Large intersubject variability is noted and no apparent dissimilarities between the GT-MSC and G-MSC cultures for any of the markers tested according to a permutation test with a Monte Carlo simulation: CD105, P = .231; CD146, P = .503; CD73, P = .654; CD106, P = .256; CD90, P = .686; SSEA-4, P = .506; CD271, P = .179; CD34, P = .563; CD45, P = .128. G, disease-free gingival connective tissue; GT, granulation tissue; MSCs, mesenchymal stem cells
| D ISCUSS I ON
The healing process of a wound occurs in at least 4 phases: coagulation, inflammation, proliferation and maturation. 21 GT has a large cell infiltrate incorporating fibroblasts, macrophages and leukocytes, as well as randomly organized collagen fibers. 22 From a clinical perspective, GT excision controls bleeding locally and thus contributes to a more efficient debridement of a periodontal osseous lesion while allowing space for the placement of graft materials. 23, 24 In both homeostasis and disease/injury, the perivascular regions in the periodontal ligament are enriched with stem/progenitor cells 25 There is growing evidence that GT-derived MSCs possess high regenerative potential and may be used as autologous transplants for subsequent periodontal reconstructive operations. 7, 8, 12 In this study, the GT was excised from residual periodontal pockets and the inflammatory infiltrate and presence of MSCs observed within this infected tissue reflected a chronic disease state, which remained unresolved. The primary interest of the current study was to address the question whether following cause-related periodontal treatment and inflammation control the F I G U R E 3 Quantification of cytokine gene expression in GT and in G specimens in the same individuals (n = 15). Statistical significant differences are shown in asterisks (*P < .05; **P < .01; ***P < .001). GT, granulation tissue; G, disease-free gingival connective tissue; IL, interleukin; TGF, transforming growth factor; TNF, tumor necrosis factor biological profile of periodontal GT, regarding MSC isolation, pro/ anti-inflammatory cytokine levels, presence/numbers of selected bacteria, could justify the clinical decision of GT surgical retention to promote the healing processes. The GT biopsies and the diseasefree connective tissue specimens contained MSC-like cells that expressed CD90, CD73, CD105, CD106, CD146 (MSC markers), as well as SSEA-4 (embryonic marker). Cells at passage 2 expressed low levels of STRO-1 (<2%-3%), 27, 28 albeit also found by other studies, 29 and of CD105 (49.2%-61.3%). 28, 29 The tissues demonstrated a high inter-subject variability regarding the expression of these markers possibly reflecting heterogeneity of the cell population and respective variability in "stemness" properties. 30 This could be attributed to several factors, ie culture conditions, disease conditions, 31 or reflect the individual genetic background and not be F I G U R E 4 Cytokine levels in GCF associated with the GT sites and with the G sites in the same individuals (n = 15). Significant differences are shown in asterisks (*P < .05; **P < .01; ***P < .001). GCF, gingival crevicular fluid; GT, granulation tissue; G, disease-free gingival connective tissue; IL, interleukin; TGF, transforming growth factor; TNF, tumor necrosis factor necessarily linked to the presence or absence of inflammation. Where the amount of TNF-α was high, the amount of IL-17E was low.
In contrast to IL-1 or IL-6, it has been shown that TNF-α increases the expression of SC markers on dental pulp-derived MSCs, telomerase activity and the capacity for migration, proliferation and differentiation. 43 These authors suggested that during the initial stage of wound healing, the inflammatory state may be of fundamental importance for both the attraction of MSCs and modulation of their "stemness" properties, while there is evidence to support that the inflammatory environment of incubation mildly influences the MSC properties of stem/progenitor cells residing in periodontal connective tissues based on in vitro and in vivo assessments. 28 The present study showed that gingival crevicular fluid levels of IL-6 from diseased sites correlated with the expression of CD105. IL-6 is thought to maintain the proliferative and undifferentiated state of bone marrow-derived MSCs, which secrete copious amounts of IL-6, until they undergo osteogenic differentiation. 44 IL-6 family cytokines have been implemented in the maintenance of embryonic
F I G U R E 5 Quantification of
Streptococcus mitis and putative periodontal pathogens in subgingival plaque samples at sites associated with the GT biopsies and G, sites in the same individuals (n = 15). Significant differences are shown in asterisks (*P < .05; **P < .01; ***P < .001). GT, granulation tissue; G, disease-free gingival connective tissue and adult SCs, [45] [46] [47] [48] [49] and in the increase of the capacity for in vitro wound healing. 44 There is contradicting evidence regarding IL-17A levels in gingival crevicular fluid, 50 saliva 50,51 and serum 50 of patients with periodontitis, but these investigations were performed on samples collected from patients with periodontitis and matched healthy controls. Of note was that in the current study, the matched samples originated from an apparently disease-free site and a single diseased site from the same individual, which during the healing process may show alterations in inflammatory regulators before overt clinical improvement occurs. A reduction of IL-17E in gingival crevicular fluid at diseased sites supports previous observations from our group that IL-17E levels in biofluids were reduced in periodontitis 50 and increased following successful periodontal therapy. 52 Median levels of IL-17E, IL-10 and TGF-β mRNAs tended to be higher in GT than disease-free tissue. Whether this is an early indication of changes within the GT to an anti-inflammatory and wound healing cytokine profile is unclear. Anti-inflammatory cytokine levels fall immediately after and remain depressed for several days following periodontal flap surgery, while levels of IL-1β and TNF-α are increased during the initial phases of wound healing. 53 Anti-inflammatory cytokines have been shown to play a key role in the disease process, 40, 41 and along with the proinflammatory cytokines, they are implicated in the healing process. 54 The inflammatory phase of a wound drives tissue healing as proinflammatory cytokines activate the proliferative phase of wound healing for the restoration of the vascular network and GT formation, 55 followed by tissue maturation and remodeling as inflammation is regulated by pro-and anti-inflammatory cytokines. although it has been shown that MSCs from inflamed tissues can exhibit altered stemness and immunomodulatory properties [56] [57] [58] that may contribute to an imbalance in the local immune response Kendal Tau correlations between subgingival plaque micro-organisms, GCF and mRNA levels of cytokines associated with diseased sites in 15 patients and correlations with CD markers in 10 patients. Additional significant correlations: CD105 correlated with IL-17E mRNA in GT (τ = .667, P = .012); CD105 correlated with IL-6 in GCF (τ = .556, P = .025); CD106 correlated with IL-17E in GCF (τ = .600, P = .016).
and advancement of alveolar bone loss. 
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